173 related articles for article (PubMed ID: 21127071)
1. Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.
Liu L; Parameswaran S; Liu J; Kim S; Wojcik EJ
J Biol Chem; 2011 Feb; 286(8):6201-10. PubMed ID: 21127071
[TBL] [Abstract][Full Text] [Related]
2. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
[TBL] [Abstract][Full Text] [Related]
3. NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.
Learman SS; Kim CD; Stevens NS; Kim S; Wojcik EJ; Walker RA
Biochemistry; 2009 Mar; 48(8):1754-62. PubMed ID: 19236100
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
[TBL] [Abstract][Full Text] [Related]
5. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
Maliga Z; Kapoor TM; Mitchison TJ
Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
[TBL] [Abstract][Full Text] [Related]
6. Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.
Wojcik EJ; Dalrymple NA; Alford SR; Walker RA; Kim S
Biochemistry; 2004 Aug; 43(31):9939-49. PubMed ID: 15287721
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity.
Zhang B; Liu JF; Xu Y; Ng SC
Biochem Biophys Res Commun; 2008 Aug; 372(4):565-70. PubMed ID: 18503753
[TBL] [Abstract][Full Text] [Related]
8. The effect of monastrol on the processive motility of a dimeric kinesin-5 head/kinesin-1 stalk chimera.
Lakämper S; Thiede C; Düselder A; Reiter S; Korneev MJ; Kapitein LC; Peterman EJ; Schmidt CF
J Mol Biol; 2010 May; 399(1):1-8. PubMed ID: 20227420
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
[TBL] [Abstract][Full Text] [Related]
10. Application of molecular modeling to analysis of inhibition of kinesin motor proteins of the BimC subfamily by monastrol and related compounds.
Bevan DR; Garst JF; Osborne CK; Sims AM
Chem Biodivers; 2005 Nov; 2(11):1525-32. PubMed ID: 17191952
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamics of nucleotide and inhibitor binding to wild-type and ispinesib-resistant forms of human kinesin spindle protein.
Sheth PR; Basso A; Duca JS; Lesburg CA; Ogas P; Gray K; Nale L; Mannarino AF; Prongay AJ; Le HV
Biochemistry; 2009 Nov; 48(46):11045-55. PubMed ID: 19824700
[TBL] [Abstract][Full Text] [Related]
13. A pathway of structural changes produced by monastrol binding to Eg5.
Maliga Z; Xing J; Cheung H; Juszczak LJ; Friedman JM; Rosenfeld SS
J Biol Chem; 2006 Mar; 281(12):7977-82. PubMed ID: 16434397
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
[TBL] [Abstract][Full Text] [Related]
15. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
[TBL] [Abstract][Full Text] [Related]
16. An allosteric transition trapped in an intermediate state of a new kinesin-inhibitor complex.
Kaan HY; Ulaganathan V; Hackney DD; Kozielski F
Biochem J; 2009 Dec; 425(1):55-60. PubMed ID: 19793049
[TBL] [Abstract][Full Text] [Related]
17. Photocontrol of mitotic kinesin Eg5 facilitated by thiol-reactive photochromic molecules incorporated into the loop L5 functional loop.
Ishikawa K; Tamura Y; Maruta S
J Biochem; 2014 Mar; 155(3):195-206. PubMed ID: 24334276
[TBL] [Abstract][Full Text] [Related]
18. The conserved L5 loop establishes the pre-powerstroke conformation of the Kinesin-5 motor, eg5.
Larson AG; Naber N; Cooke R; Pate E; Rice SE
Biophys J; 2010 Jun; 98(11):2619-27. PubMed ID: 20513406
[TBL] [Abstract][Full Text] [Related]
19. Determinants of kinesin motor polarity.
Endow SA; Waligora KW
Science; 1998 Aug; 281(5380):1200-2. PubMed ID: 9712586
[TBL] [Abstract][Full Text] [Related]
20. Processivity of the kinesin-2 KIF3A results from rear head gating and not front head gating.
Chen GY; Arginteanu DF; Hancock WO
J Biol Chem; 2015 Apr; 290(16):10274-94. PubMed ID: 25657001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
